85 related articles for article (PubMed ID: 14648028)
1. Unusual and severe symptomatic impairment of neutrophil function after one cycle of temozolomide in patients with malignant glioma.
Hartmann P; Herholz K; Salzberger B; Petereit HF
Ann Hematol; 2004 Apr; 83(4):212-7. PubMed ID: 14648028
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
3. How lymphotoxic is dose-intensified temozolomide? The glioblastoma experience.
Wick W; Weller M
J Clin Oncol; 2005 Jun; 23(18):4235-6; author reply 4236. PubMed ID: 15961774
[No Abstract] [Full Text] [Related]
4. Non-Hodgkin's lymphoma in a patient on treatment with temozolomide.
Otty Z; Sabesan S
Asia Pac J Clin Oncol; 2012 Dec; 8(4):e53-4. PubMed ID: 22897453
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide-induced flare in high-grade gliomas: a new clinical entity.
Rosenthal MA; Ashley DL; Cher L
Intern Med J; 2002 Jul; 32(7):346-8. PubMed ID: 12088355
[TBL] [Abstract][Full Text] [Related]
6. Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial.
Mason WP; Cairncross JG
Nat Clin Pract Neurol; 2005 Dec; 1(2):88-95. PubMed ID: 16932504
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide (Temodar).
Wesolowski JR; Rajdev P; Mukherji SK
AJNR Am J Neuroradiol; 2010 Sep; 31(8):1383-4. PubMed ID: 20538821
[TBL] [Abstract][Full Text] [Related]
8. An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.
Harris MT; Rosenthal MA; Ashley DL; Cher L
J Clin Neurosci; 2001 Jul; 8(4):325-7. PubMed ID: 11437571
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of temozolomide using an extended continuous oral schedule.
Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
[TBL] [Abstract][Full Text] [Related]
10. [Temozolomide, an oral chemotherapeutic agent with potential severe toxicity].
Soetekouw PM; Gijtenbeek JM; van der Maazen RW; Kappelle AC; van Herpen CM
Ned Tijdschr Geneeskd; 2007 Jan; 151(4):253-7. PubMed ID: 17323884
[TBL] [Abstract][Full Text] [Related]
11. Management of cytomegalovirus infection in a patient with malignant glioma treated with temozolomide and steroids.
Okita Y; Narita Y; Miyakita Y; Ohno M; Nagai S; Shibui S
Intern Med; 2012; 51(20):2967-71. PubMed ID: 23064578
[TBL] [Abstract][Full Text] [Related]
12. Fatal pneumonia associated with temozolomide therapy in patients with malignant glioma.
Hayashi H; Saito Y; Kokuho N; Morimoto T; Kobayashi K; Tanaka T; Abe S; Fujita K; Azuma A; Gemma A
Jpn J Clin Oncol; 2012 Jul; 42(7):632-6. PubMed ID: 22525211
[TBL] [Abstract][Full Text] [Related]
13. Is protracted low-dose temozolomide feasible in glioma patients?
Tosoni A; Cavallo G; Ermani M; Scopece L; Franceschi E; Ghimenton C; Gardiman M; Pasetto L; Blatt V; Brandes AA
Neurology; 2006 Feb; 66(3):427-9. PubMed ID: 16476947
[TBL] [Abstract][Full Text] [Related]
14. Is protracted low-dose temozolomide feasible in glioma patients?
Wong ET
Neurology; 2006 Aug; 67(3):543-4; author reply 543-4. PubMed ID: 16894133
[No Abstract] [Full Text] [Related]
15. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide in malignant gliomas.
Yung WK
Semin Oncol; 2000 Jun; 27(3 Suppl 6):27-34. PubMed ID: 10866347
[TBL] [Abstract][Full Text] [Related]
17. Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
Villano JL; Collins CA; Manasanch EE; Ramaprasad C; van Besien K
Lancet Oncol; 2006 May; 7(5):436-8. PubMed ID: 16648049
[No Abstract] [Full Text] [Related]
18. Temozolomide and treatment of malignant glioma.
Friedman HS; Kerby T; Calvert H
Clin Cancer Res; 2000 Jul; 6(7):2585-97. PubMed ID: 10914698
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide-associated organizing pneumonitis.
Maldonado F; Limper AH; Lim KG; Aubrey MC
Mayo Clin Proc; 2007 Jun; 82(6):771-3. PubMed ID: 17550757
[TBL] [Abstract][Full Text] [Related]
20. Concomitant viral and bacterial encephalitis after temozolomide for glioblastoma.
Tsai JP; Petrescu N; Mason WP; Casaubon LK
Can J Neurol Sci; 2014 Jan; 41(1):84-5. PubMed ID: 24384343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
